WELL Health Technologies (WELL) Stock Overview
Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for WELL from our risk checks.
WELL Community Fair Values
Create NarrativeSee what 111 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
WELL Health Technologies Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$4.27 |
| 52 Week High | CA$6.08 |
| 52 Week Low | CA$3.58 |
| Beta | 1.29 |
| 1 Month Change | 9.49% |
| 3 Month Change | 7.56% |
| 1 Year Change | 8.10% |
| 3 Year Change | -27.13% |
| 5 Year Change | -39.52% |
| Change since IPO | 2,654.84% |
Recent News & Updates
WELL: Future Upside Will Rely On Executing Margin And Cost Improvements
Analysts have trimmed their average 12 month price target on WELL Health Technologies by about CA$0.50, reflecting updated assumptions on discount rates, long term growth and margins, while keeping the overall fair value view broadly unchanged. Analyst Commentary Recent research suggests that the modest trim to the CA$0.50 12 month price target reflects fine tuning of models rather than a wholesale change in how the business is viewed.WELL: Future Upside Will Depend On Executing Margin Improvement Plans
Analysts have trimmed their CA$ price target on WELL Health Technologies by CA$0.50, pointing to updated assumptions for discount rates, revenue growth, profit margins, and a higher future P/E multiple in their models. Analyst Commentary Recent research points to a mixed but generally constructive stance on WELL Health Technologies, with the latest CA$0.50 reduction in the price target reflecting more conservative modeling rather than a wholesale shift in thesis.WELL: Long Term Digital Health Platform Will Rely On Margin Improvement
Analysts have trimmed their price target on WELL Health Technologies to about CA$7.07 from CA$7.67. This reflects updated assumptions for slower revenue growth, lower profit margins, a higher discount rate and a higher future P/E multiple in their models.Recent updates
WELL: Future Upside Will Rely On Executing Margin And Cost Improvements
Analysts have trimmed their average 12 month price target on WELL Health Technologies by about CA$0.50, reflecting updated assumptions on discount rates, long term growth and margins, while keeping the overall fair value view broadly unchanged. Analyst Commentary Recent research suggests that the modest trim to the CA$0.50 12 month price target reflects fine tuning of models rather than a wholesale change in how the business is viewed.WELL: Future Upside Will Depend On Executing Margin Improvement Plans
Analysts have trimmed their CA$ price target on WELL Health Technologies by CA$0.50, pointing to updated assumptions for discount rates, revenue growth, profit margins, and a higher future P/E multiple in their models. Analyst Commentary Recent research points to a mixed but generally constructive stance on WELL Health Technologies, with the latest CA$0.50 reduction in the price target reflecting more conservative modeling rather than a wholesale shift in thesis.WELL: Long Term Digital Health Platform Will Rely On Margin Improvement
Analysts have trimmed their price target on WELL Health Technologies to about CA$7.07 from CA$7.67. This reflects updated assumptions for slower revenue growth, lower profit margins, a higher discount rate and a higher future P/E multiple in their models.
WELL: Future Upside Will Depend On Margin Expansion And Lower P E Multiple
Analysts have trimmed their average price target on WELL Health Technologies by CA$0.01. This reflects updated assumptions that now point to slightly higher modeled revenue growth and profit margins, along with a modestly lower future P/E multiple.WELL: Future Upside Will Rely On Margin Expansion And Lower P E Multiple
Analysts trimmed their price target on WELL Health Technologies by C$0.50, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin, and the future P/E they see as appropriate for the stock. Analyst Commentary Recent research updates on WELL Health Technologies highlight a more conservative stance among some bearish analysts, who are reassessing what they see as fair value for the shares.WELL: Future Margin Expansion Will Be Driven By Completed Share Buybacks
Analysts have inched their fair value estimate for WELL Health Technologies slightly lower to about C$5.63 from roughly C$5.67, as recent Street research, including CIBC's move to trim its price target from C$6.00 to C$5.50 while maintaining a Neutral stance, reflects updated views on revenue growth, margins, and valuation. Analyst Commentary Recent Street research on WELL Health Technologies has been mixed, with some firms trimming fair value estimates and price targets while keeping a Neutral stance.WELL: Future Margin Expansion And Sector Tailwinds Will Support Upside
Analysts trimmed their price target on WELL Health Technologies to C$5.50 from C$6.00, reflecting updated assumptions around profit margins and a lower future P/E. They maintained a Neutral stance on the shares.WELL: Long Term Earnings Visibility And Sector Tailwinds Will Support Upside
Analysts have nudged their price target on WELL Health Technologies slightly higher, lifting fair value by about C$0.07 to reflect a more conservative outlook on growth and margins, which is offset by improved long term earnings visibility and sector tailwinds. Analyst Commentary Recent Street research on WELL Health Technologies reflects a more nuanced stance, with upbeat sector dynamics tempered by company specific execution and valuation questions.Take Care Before Jumping Onto WELL Health Technologies Corp. (TSE:WELL) Even Though It's 27% Cheaper
Nov 26
Even With A 29% Surge, Cautious Investors Are Not Rewarding WELL Health Technologies Corp.'s (TSE:WELL) Performance Completely
Oct 09WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 16Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)
Apr 23Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts
Apr 22WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%
Apr 01Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?
Mar 29
AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline
Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well
Dec 31A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb
Nov 29When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?
Nov 11Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher
Jul 05WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price
Jun 11WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem
May 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?
Feb 29The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)
Jan 18WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30Shareholder Returns
| WELL | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | -0.7% | 3.0% | 0.1% |
| 1Y | 8.1% | 32.2% | 35.1% |
Return vs Industry: WELL underperformed the Canadian Healthcare industry which returned 32.2% over the past year.
Return vs Market: WELL underperformed the Canadian Market which returned 35.1% over the past year.
Price Volatility
| WELL volatility | |
|---|---|
| WELL Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 10.6% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.9% |
Stable Share Price: WELL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: WELL's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Hamed Shahbazi | well.company |
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women’s health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners.
WELL Health Technologies Corp. Fundamentals Summary
| WELL fundamental statistics | |
|---|---|
| Market cap | CA$1.09b |
| Earnings (TTM) | -CA$7.36m |
| Revenue (TTM) | CA$1.40b |
Is WELL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WELL income statement (TTM) | |
|---|---|
| Revenue | CA$1.40b |
| Cost of Revenue | CA$781.34m |
| Gross Profit | CA$618.84m |
| Other Expenses | CA$626.20m |
| Earnings | -CA$7.36m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
May 07, 2026
| Earnings per share (EPS) | -0.029 |
| Gross Margin | 44.20% |
| Net Profit Margin | -0.53% |
| Debt/Equity Ratio | 60.0% |
How did WELL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/03 14:12 |
| End of Day Share Price | 2026/05/01 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
WELL Health Technologies Corp. is covered by 14 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyle McPhee | ATB Cormark |
| Gabriel Leung | Beacon Securities Limited |
| Douglas Taylor | Canaccord Genuity |